The Role of Statins in Dementia or Alzheimer's Disease Incidence: a Systematic Review and Meta-analysis of Cohort Studies

Overview

Journal Front Pharmacol

Date 2025 Feb 18

PMID 39963242

Authors

Ye Du

Zhangjie Yu

Chengyi Li

Yanxing Zhang

Buyun Xu

Affiliations

Soon will be listed here.

Abstract

Background: The effect of statins on the risk of dementia and Alzheimer's disease (AD) is unclear.

Methods: We systematically searched EMBASE, Web of Science, PubMed, CENTRAL and ClinicalTrail.gov for cohort studies comparing incidence of new-onset dementia and AD between statin users and non-users. We applied the DerSimonian-Laird random effects method to pool hazard ratio (HR) with 95% confidence intervals (CI).

Results: We included forty-two studies comprising 6,325,740 patients. Thirty-five cohort studies involving 6,306,043 participants were pooled and indicated that statin use was associated with a reduced risk of dementia (HR: 0.79, 95% CI: 0.71-0.88). Similarly, an analysis of 19 studies comprising 1,237,341 participants demonstrated a 29% decrease in the risk of AD among statin users (HR: 0.71, 95% CI: 0.60-0.85). In sensitivity analyses, diagnostic criteria for dementia/AD significantly affected the combined risk estimates. In subgroup analyses, compared to studies enrolling participants with a mean/median age over 70 years, those younger than 70 years exhibited greater efficacy of statins in preventing dementia (HR: 0.67, 95% CI: 0.56-0.81 vs HR: 0.86, 95% CI: 0.78-0.95; P = 0.02) and AD (HR: 0.47, 95% CI: 0.44-0.50 vs. HR: 0.81, 95% CI: 0.71-0.92; P < 0.01). Due to significant heterogeneity in the definitions of statin dosage and exposure duration, pooling the results was abandoned and most studies suggested that higher dosages and longer exposure duration of statins further reduce the risk of dementia and AD.

Conclusion: Statin use is associated with a reduced incidence of dementia and AD, which might be modified by ages.

References

Lee J, Choi E, Kim Y, Kim Y, You H, Han Y . Statin exposure and the risk of dementia in individuals with hypercholesterolaemia. J Intern Med. 2020; 288(6):689-698. DOI: 10.1111/joim.13134. View

Yang Y, Teng H, Lai Y, Li S, Lin C, Yang A . Statins Reduces the Risk of Dementia in Patients with Late-Onset Depression: A Retrospective Cohort Study. PLoS One. 2015; 10(9):e0137914. PMC: 4575094. DOI: 10.1371/journal.pone.0137914. View

Kim M, Jung M, Noh Y, Shin S, Hong C, Lee S . Impact of Statin Use on Dementia Incidence in Elderly Men and Women with Ischemic Heart Disease. Biomedicines. 2020; 8(2). PMC: 7168191. DOI: 10.3390/biomedicines8020030. View

Sparks D, Kryscio R, Sabbagh M, Connor D, Sparks L, Liebsack C . Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res. 2008; 5(4):416-21. DOI: 10.2174/156720508785132316. View

Kim M, Yuan S, Lee K, Jin X, Song Z, Park J . Statin therapy reduces dementia risk in atrial fibrillation patients receiving oral anticoagulants. Eur Heart J Cardiovasc Pharmacother. 2023; 9(5):421-426. DOI: 10.1093/ehjcvp/pvad039. View

Jong G, Lin T, Huang J, Liao P, Yang T, Pan L . Risk of New-Onset Dementia in Patients with Chronic Kidney Disease on Statin Users: A Population-Based Cohort Study. Biomedicines. 2023; 11(4). PMC: 10135687. DOI: 10.3390/biomedicines11041073. View

Zhou B, Lin C, Kojima S, Fukushima M, Hsu C . Risk Factors of Dementia in Patients with Cerebral Vascular Diseases Based on Taiwan National Health Insurance Data. Dement Geriatr Cogn Disord. 2023; 52(3):184-192. PMC: 10332482. DOI: 10.1159/000530102. View

Li G, Higdon R, Kukull W, Peskind E, Van Valen Moore K, Tsuang D . Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology. 2004; 63(9):1624-8. DOI: 10.1212/01.wnl.0000142963.90204.58. View

Smeeth L, Douglas I, Hall A, Hubbard R, Evans S . Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol. 2008; 67(1):99-109. PMC: 2668090. DOI: 10.1111/j.1365-2125.2008.03308.x. View

10.

Bettermann K, Arnold A, Williamson J, Rapp S, Sink K, Toole J . Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study. J Stroke Cerebrovasc Dis. 2011; 21(6):436-44. PMC: 3140577. DOI: 10.1016/j.jstrokecerebrovasdis.2010.11.002. View

11.

Wetterberg H, Najar J, Rydberg Sterner T, Kern S, Skoog I . The Effect of Diagnostic Criteria on Dementia Prevalence - A Population-Based Study From Gothenburg, Sweden. Am J Geriatr Psychiatry. 2023; 32(2):230-243. DOI: 10.1016/j.jagp.2023.08.018. View

12.

Rajan K, McAninch E, Wilson R, Dhana A, Evans-Lacko S, Evans D . Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults. Neurology. 2024; 102(7):e209168. PMC: 11770690. DOI: 10.1212/WNL.0000000000209168. View

13.

Zandi P, Sparks D, Khachaturian A, Tschanz J, Norton M, Steinberg M . Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry. 2005; 62(2):217-24. DOI: 10.1001/archpsyc.62.2.217. View

14.

Lee C, Chang C, Lin C, Yeh C, Hu C, Wu C . Risk of dementia in patients with periodontitis and related protective factors: A nationwide retrospective cohort study. J Clin Periodontol. 2020; 47(12):1428-1436. DOI: 10.1111/jcpe.13372. View

15.

Chitnis A, Aparasu R, Chen H, Kunik M, Schulz P, Johnson M . Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study. Drugs Aging. 2015; 32(9):743-54. DOI: 10.1007/s40266-015-0295-4. View

16.

Chou C, Chou Y, Chou Y, Yang Y, Huang N . Statin use and incident dementia: a nationwide cohort study of Taiwan. Int J Cardiol. 2014; 173(2):305-10. DOI: 10.1016/j.ijcard.2014.03.018. View

17.

Wolozin B, Wang S, Li N, Lee A, Lee T, Kazis L . Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med. 2007; 5:20. PMC: 1955446. DOI: 10.1186/1741-7015-5-20. View

18.

Chang C, Liou Y, Lin T, Ma S, Hu Y, Chen H . High exposure to statins decrease the risk of new-onset dementia: A nationwide population-based longitudinal cohort study. Medicine (Baltimore). 2019; 98(34):e16931. PMC: 6716753. DOI: 10.1097/MD.0000000000016931. View

19.

Rea T, Breitner J, Psaty B, Fitzpatrick A, Lopez O, Newman A . Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol. 2005; 62(7):1047-51. DOI: 10.1001/archneur.62.7.1047. View

20.

Goldstein L, Toth P, Dearborn-Tomazos J, Giugliano R, Hirsh B, Pena J . Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2023; 43(10):e404-e442. DOI: 10.1161/ATV.0000000000000164. View